Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.
Open | $12.03 |
Close | $12.25 |
Volume / Avg. | 398.45K / 961.80K |
Day Range | 11.85 - 12.64 |
52 Wk Range | 10.93 - 25.05 |
Market Cap | $747.04M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 17.28% |
Days to Cover | 9.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
Other companies in Viridian Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT) and Centessa Pharmaceuticals (NASDAQ:CNTA).
There is no analysis for Viridian Therapeutics.
Viridian Therapeutics has a consensus price target of $32.28.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $11.705 last updated July 3, 2024 at 1:18 PM EDT.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.